TruBridge (TBRG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 May, 2026Executive summary
A special meeting will be held for shareholders to vote on the proposed merger of TruBridge, Inc. with IKS Next Horizon, Inc., a subsidiary of Inventurus Knowledge Solutions, Inc. (IKS), making TruBridge a wholly owned subsidiary of IKS.
Shareholders will receive $26.25 in cash per share, representing a 14.7% premium over the pre-announcement price, 49% over the price before a delayed 10-K filing, and 87.5% over the unaffected price before the strategic review announcement.
The board unanimously recommends voting in favor of the merger and related executive compensation proposals, citing a robust sale process, premium valuation, and certainty of cash consideration.
The merger is subject to regulatory approvals, including antitrust clearance and approval of TopCo shareholders for debt financing.
Voting matters and shareholder proposals
Shareholders will vote on (1) the adoption of the Merger Agreement and (2) a non-binding, advisory vote on compensation for named executive officers related to the merger.
Approval of the merger requires a majority of outstanding shares; the compensation proposal requires a majority of votes cast.
Major shareholders (Pinetree, L6 Holdings, Ocho Investments) have entered into support agreements to vote in favor of the merger and waive appraisal rights.
Abstentions and broker non-votes count as votes against the merger but have no effect on the compensation proposal.
Board of directors and corporate governance
The board conducted a comprehensive strategic review, including outreach to 60 potential buyers and engagement with financial and legal advisors.
The board determined the merger is in the best interests of shareholders, considering alternatives and the risks of continued independence.
The board consists of a majority of independent directors and followed a process to avoid conflicts of interest.
Latest events from TruBridge
- Shareholders to vote on a premium cash merger with IKS; board and major holders support the deal.TBRG
Proxy filing4 Jun 2026 - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 20268 May 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing23 Apr 2026 - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing23 Apr 2026 - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing23 Apr 2026 - Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026 - RCM gains and margin expansion offset EHR declines as full-year guidance is reaffirmed.TBRG
Q2 20242 Feb 2026 - RCM growth, offshoring, and analytics drive TruBridge's margin and operational focus.TBRG
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Revenue and bookings rose, but net loss widened and internal control weaknesses persisted.TBRG
Q3 202415 Jan 2026